Metabolic Syndrome and NASH: Risk for HCC

被引：0
|
作者：
不详
机构：
来源：
DIABETES STOFFWECHSEL UND HERZ | 2022年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [31] Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017-2018
    Payne, Julia Y.
    Alkhouri, Naim
    Le, Phuc
    Rothberg, Michael B.
    Polanco, Prido
    Sakkal, Celine
    Dasarathy, Srinivasan
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (01)
  • [32] Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
    Gutierrez-Cuevas, Jorge
    Lucano-Landeros, Silvia
    Lopez-Cifuentes, Daniel
    Santos, Arturo
    Armendariz-Borunda, Juan
    CANCERS, 2023, 15 (01)
  • [33] PROTEOMIC MARKERS OF CARDIOVASCULAR AND METABOLIC HEALTH IN AT-RISK NASH
    Simpson, Missy
    Alexander, Leigh
    Ratziu, Vlad
    Bugianesi, Elisabetta
    Boursier, Jerome
    Govaere, Olivier
    Tiniakos, Dina
    Wonders, Krysty
    Vali, Yasaman
    Lee, Jenny
    Schattenberg, Joern M.
    Bossuyt, Patrick
    Anstee, Quentin M.
    Williams, Stephen
    Ostroff, Rachel
    HEPATOLOGY, 2022, 76 : S608 - S609
  • [34] Outcome of Liver Resection for Metabolic Syndrome Related HCC: A Comparative Study With Viral and Alcohol Related HCC
    Ruzzenente, Andrea
    De Angelis, Michela
    Conci, Simone
    Bagante, Fabio
    Valdegamberi, Alessandro
    Bertuzzo, Francesca
    Iacono, Calogero
    Guglielmi, Alfredo
    GASTROENTEROLOGY, 2015, 148 (04) : S1114 - S1114
  • [35] An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome
    Kumari, Reena
    Kumar, Sandeep
    Kant, Ravi
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (04) : 2409 - 2417
  • [36] T cell drivers in NASH-HCC
    O'Leary, Karen
    NATURE REVIEWS CANCER, 2021, 21 (06) : 341 - 341
  • [37] Mitochondrial Dysfunction in the Transition from NASH to HCC
    Leveille, Melissa
    Estall, Jennifer L.
    METABOLITES, 2019, 9 (10)
  • [38] Is That Possible to Stop or Cease the NASH to Turn into HCC?
    Uygun A.
    Journal of Gastrointestinal Cancer, 2017, 48 (3) : 250 - 255
  • [39] Should Patients With NAFLD/NASH Be Surveyed for HCC?
    Reig, Maria
    Gambato, Martina
    Man, Nancy Kwan
    Roberts, John P.
    Victor, David
    Orci, Lorenzo A.
    Toso, Christian
    TRANSPLANTATION, 2019, 103 (01) : 39 - 44
  • [40] T cell drivers in NASH-HCC
    Karen O’Leary
    Nature Reviews Cancer, 2021, 21 : 341 - 341
12345